Stereotaxis STXS
NYSE STXS
$1.20 -0.03 (-2.85%)
As of: Oct 1, 2026 · 3:59 PM EDT

Stereotaxis (STXS) Other financing activities (2016 - 2026)

Updated

Stereotaxis' Other financing activities came in at $137,000 for Q1 2026.

Analysis

Stereotaxis (STXS) Other financing activities (2016 - 2026) Analysis & Trends

For FY2025, Stereotaxis' Other financing activities was $893,000.

  • The Q1 2026 figure represents the lowest quarterly Other financing activities since Q1 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Stereotaxis 124.25 Mn 124.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 137,000.00
Mar 31, 2017 100,000.00
Mar 31, 2016 100,000.00
API Access

Stereotaxis Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=STXS&period=max&api_key=YOUR_API_KEY